Intellectual Property

  • December 16, 2024

    The Biggest Patent Decisions Of 2024

    This year's notable patent decisions from the Federal Circuit provided clearer guidelines on double patenting and opened the door for new ways to invalidate design patents. Here's a look at the cases from 2024 that will shape patent litigation going forward.

  • December 16, 2024

    Allele, Regeneron Settle COVID Treatment Patent Suit

    Allele Biotechnology and Regeneron Pharmaceuticals have settled litigation accusing the latter of infringing a patent used in developing treatments and vaccines for COVID-19, a New York federal judge said Monday.

  • December 16, 2024

    Supreme Court Rejects Salix Appeal In IBS Drug Case

    The U.S. Supreme Court has turned away a bid by a Bausch Health unit to undo a Federal Circuit ruling that invalidated some of its patents on a blockbuster drug for irritable bowel syndrome with diarrhea.

  • December 16, 2024

    Knicks Blame Raptors Arbitration Delay On Silver 'Conflict'

    The New York Knicks reiterated their claim that National Basketball Association commissioner Adam Silver is biased against the franchise and incapable of arbitrating their data-theft dispute with the Toronto Raptors, accusing Silver of a "clear conflict of interest.''

  • December 16, 2024

    High Court Bar's Future: Latham's Roman Martinez

    Roman Martinez of Latham & Watkins LLP approaches oral arguments before the U.S. Supreme Court as if they were just another dinner with family or friends — people he's argued with since he was a kid.

  • December 16, 2024

    Chipmaker Arm Settles UPC, US IP Litigation With Rival

    The Unified Patent Court has granted two computer chip companies permission to pull out of their litigation in Europe after the pair inked an agreement ending their parallel U.S. feud.

  • December 16, 2024

    Gibson Dunn Guides Vera Wang In Sale Of IP To WHP Global

    New York-based brand management firm WHP Global, advised by Kirkland & Ellis LLP and Pryor Cashman LLP, on Monday announced that it has agreed to buy all the intellectual property of Gibson Dunn & Crutcher LLP-advised luxury designer brand Vera Wang.

  • December 13, 2024

    NCAA, Pac-12, USC Say Reggie Bush Filed NIL Suit Too Late

    The NCAA, the University of Southern California and the Pac-12 Conference urged a Los Angeles state court to toss former USC star running back Reggie Bush's lawsuit accusing them of profiting off his fame without compensating him, saying Bush waited "far too long" to sue.

  • December 13, 2024

    Prindle Goetz Says Attys Took Trade Secrets To Rival Firm

    Prindle Goetz Barnes & Reinholtz LLP sued two former nonequity partners in California state court Thursday, accusing them of taking its confidential billing, compensation and client listing information with them in late 2022 before jumping to a rival law firm launched by a former equity owner at the law firm.

  • December 13, 2024

    Liner Co. Seeks PTAB Sanctions For Alleged False Testimony

    After receiving the Patent Trial and Appeal Board's green light Friday, Omega Liner Co. quickly requested sanctions against German packaging company Buergofol GmbH, whose liner patent Omega is challenging, accusing Buergofol's counsel of knowingly submitting false testimony to the board.

  • December 13, 2024

    UK Litigation Roundup: Here's What You Missed In London

    This past week in London has seen a group of franchise operators hit Vodafone with a £120 million ($151 million) claim for allegedly imposing commission cuts, green energy tycoon Dale Vince pursue another libel action against the publisher of the Daily Mail, and parcel delivery giant Yodel face a claim by an investor that helped save it from collapse earlier in the year.

  • December 13, 2024

    Judge Finds Wireless Patent Claim Indefinite In Samsung Feud

    A Delaware federal magistrate judge has sided with Samsung on how to interpret a key claim in a wireless communications patent it was accused of infringing, finding the term was indefinite.

  • December 13, 2024

    Tesla Gets PTAB To Cut Some Claims In 2 AI Vehicle Patents

    The Patent Trial and Appeal Board has found that most of the challenged claims across two patents related to the use of artificial intelligence in self-driving vehicles are invalid, handing a win to challenger Tesla.

  • December 13, 2024

    ITC To Review Design Patent Case Over Blue-Soled Shoes

    The U.S. International Trade Commission has agreed to investigate whether a New York-based company and a group of overseas entities are importing women's flats that infringe design patents belonging to the maker of Tieks shoes.

  • December 13, 2024

    ByteDance Ex-Coder Perjured Himself In Suit, Judge Finds

    A California federal judge imposed terminating sanctions against a former engineer at TikTok's parent company, finding he committed perjury in a suit alleging he was wrongly fired and ordered the dispute to arbitration.

  • December 13, 2024

    'Copycat' Nantucket Wine Event Ordered To Issue Retraction

    A Massachusetts liquor distributor was ordered Friday by a federal judge to post a bold-type correction and issue press releases retracting claims that it had acquired and "re-branded" a long-running Nantucket wine and food festival.

  • December 13, 2024

    What's Left In $400M Skinny Label Row? A Lot, Court Says

    A number of key issues remain live in the $400 million fight between Teva Pharmaceuticals and GlaxoSmithKline over whether the generic-drug maker induced healthcare providers to infringe the brand-name company's heart drug patent, including the availability of a new trial, a Delaware federal judge has said.

  • December 13, 2024

    Ex-Judges, Atty Group Back Newman In Suspension Lawsuit

    U.S. Circuit Judge Pauline Newman has received more support at the D.C. Circuit in her case over the suspension her colleagues imposed on her for refusing to participate in an investigation into her fitness to serve as a Federal Circuit judge, this time from a group of former federal judges and the Bar Association of the District of Columbia.

  • December 13, 2024

    Off The Bench: PE Buys In On NFL, WWE Abuse Suit Back On

    In this week's Off The Bench, two teams usher in a new era for the NFL by bringing in private equity investors, a suit accusing the WWE and Vince McMahon of sexual abuse and trafficking picks back up while a federal investigation continues, and a private equity giant and NHL owner passes away.

  • December 12, 2024

    Moderna Fires Back With Counterclaims In GSK RSV Vax Suit

    Moderna Inc. on Thursday lodged counterclaims in Delaware federal court accusing GlaxoSmithKline of failing to develop its own vaccine for respiratory syncytial virus, and then "resorting to the courtroom" and GSK's "manipulation of the United States patent system" to go after Moderna.

  • December 12, 2024

    WGA Urges Major Studios To Take Legal Action Over AI 'Theft'

    The Writers Guild of America on Wednesday called on several major entertainment studios to swiftly take legal action against technology companies they assert are stealing writers' works to train artificial intelligence systems and making billions of dollars from the "wholesale theft."

  • December 12, 2024

    Vidal Reflects On USPTO Achievements As She Leaves Office

    Kathi Vidal will serve her last day as U.S. Patent and Trademark Office director on Friday and rejoin her former firm, Winston & Strawn LLP, on Monday. She talked to Law360 as she prepared her exit from the agency, with internal changes top of mind as she looked back on her tenure.

  • December 12, 2024

    Align Tech's $27.5M Antitrust Deal Hits Nerve With Judge

    A California federal judge said Thursday that a proposed $27.5 million deal for teeth-aligner buyers to resolve antitrust claims alleging Align Technologies Inc. colluded with the now-bankrupt SmileDirectClub to illegally restrict competition might be "inherently improper" due to a coupon component that "would bring additional business to the monopolist."

  • December 12, 2024

    Carlisle Cleared In Patent Trial Over Spray Guns

    Jurors cleared Carlisle's construction materials company on Thursday from allegations in Delaware federal court that the Pennsylvania company was infringing a single claim in a rival's patent that covered a spray gun marketed to construction workers.

  • December 12, 2024

    T-Mobile Says Split On TM Use Must Be Resolved By Justices

    T-Mobile is asking the U.S. Supreme Court to review a Fourth Circuit panel's revival of a prepaid cellphone company's trademark infringement suit, telling the justices in a new petition this week that trademarks should have to be in continuous use for their holders to be able to protect them.

Expert Analysis

  • TM Suit Over Google AI Name Points To New Branding Issues

    Author Photo

    Gemini Data’s recent lawsuit in California federal court alleging Google’s rebranded artificial intelligence chatbot stole its name may have broader implications for the scope of trademark rights for AI-related products and highlights that an evolving marketplace may force companies to recalibrate how they protect their brands, say attorneys at ArentFox Schiff.

  • Presidential Campaign Errors Provide Lessons For Trial Attys

    Author Photo

    Vice President Kamala Harris’ presidential campaign employed numerous strategies that evidently didn’t land, and trial attorneys should take note, because voters and jurors are both decision-makers who are listening for how one’s case presentation would affect them personally, says Reuben Guttman at Guttman Buschner.

  • How Patent Landscape Analysis Drives Business Growth

    Author Photo

    Keegan Caldwell at Caldwell Law explores how patent landscape analysis serves as a key driver of sustainable growth — examining how its components, strategic advantages and implementation best practices are reshaping innovation leadership.

  • Marching In On Orange Book Drugs May Have Limited Effect

    Author Photo

    Statistical analysis shows that marching in on Orange Book drug patent holders to require additional licensees would have a relatively minimal impact on drug prices, and should be weighed against the harms it could have on pharmaceutical innovation, say researchers at Competition Dynamics.

  • Series

    Being A Navy Reservist Makes Me A Better Lawyer

    Author Photo

    Serving this country in uniform has not only been one of the greatest honors of my life, but it has also provided me with opportunities to broaden my legal acumen and interpersonal skills in ways that have indelibly contributed to my civilian practice, says Phillip Smith at Weinberg Wheeler.

  • Navigating DOJ's Patchwork Whistleblower Regime

    Author Photo

    In the past few months, the U.S. Department of Justice and several individual U.S. attorney’s offices have issued different pilot programs aimed at incentivizing individuals to blow the whistle on misconduct, but this piecemeal approach may create confusion and suboptimal outcomes, say attorneys at BakerHostetler.

  • So You Want To Move Your Law Practice To Canada, Eh?

    Author Photo

    Google searches for how to move to Canada have surged in the wake of the U.S. presidential election, and if you’re an attorney considering a move to the Great White North, you’ll need to understand how the practice of law differs across the border, says David Postel at Henein Hutchison.

  • When Arbitration Is Effective For Employment And IP Cases

    Author Photo

    Widespread adoption of arbitration has revolutionized conflict resolution in employment law, and the benefits of speed, expertise and confidentiality make it an increasingly attractive alternative for resolving patent conflicts — but arbitration is not a silver bullet, say Brandon Miller at Fisher Phillips and Camilla Bykhovsky at Turner Boyd.

  • US Intellectual Property-Based Sanctions Could Be Imminent

    Author Photo

    A recent presidential delegation suggests that regulators may be ready to wield the sanctions authority found in the Protecting American Intellectual Property Act, which has been unutilized for the first 22 months of its life, say attorneys at Morgan Lewis.

  • Key Territory-Split Licensing Lessons For Life Sciences Cos.

    Author Photo

    Territory-split deals can allow life sciences companies to maximize products' potential across a range of geographic areas, but these deals also present unique challenges requiring highly bespoke structures that can make or break the value of an asset, say attorneys at Covington.

  • A Look At 2024 NIL Rights And Economies In College Sports

    Author Photo

    Permutations in the arena of name, image and likeness affecting collegiate athletics have continued unabated this year, and practitioners and industry representatives should anticipate significant activity at schools and continuing legal changes at the state level, say attorneys at Pillsbury.

  • Legislation Most Likely To Pass In Lame Duck Session

    Author Photo

    As Congress begins its five-week post-election lame duck session, attorneys at Greenberg Traurig break down the legislative priorities and which proposals can be expected to pass.

  • Copyright Questions Surround AI Music Platform Suits

    Author Photo

    If recent lawsuits filed by the Recording Industry Association of America against two artificial intelligence music platform developers — who maintain that use of copyrighted works to train AI models constitutes fair use — go to trial, this novel issue will make for potentially precedent-setting decisions, says intellectual property lawyer Eric Lane.

  • Patent Marking Steps After Fed. Circ. Opens Lanham Act Door

    Author Photo

    Following the Federal Circuit’s recent ruling in Crocs v. Effervescent, which seemingly revives private actors’ ability to bring false patent marking claims under the Lanham Act, marketing and legal teams should be careful to avoid advertisement language that implies nonexistent patent rights, says Jeffrey Ratinoff at Spencer Fane.

  • Litigation Strategies In View Of New Double Patenting Rulings

    Author Photo

    Recent Federal Circuit decisions, including in Allergan v. MSN, raise several issues that patent owners should understand and consider addressing proactively regarding obviousness-type double patenting, at least in their prosecution strategies, say attorneys at Dentons.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Intellectual Property archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!